Research programme: apoptosis inducers - Aponetics AG
Alternative Names: Apo 1; Apo 2; Apo 3; APO1-4; Apoptosis inducers research programme: Aponetics AGLatest Information Update: 02 Oct 2021
At a glance
- Originator Aponetics
- Class
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 25 Nov 2004 Discontinued - Preclinical for Cancer in Switzerland (unspecified route)
- 25 Mar 2004 Preclinical trials in Cancer in Switzerland (unspecified route)